AKT1 and hepatocellular carcinoma: Furthermore, the activation of distinct EGF-receptor signaling pathways (especially the two pathways: Ras–Raf–MEK–ERK and PI3K–AKT–mTOR) are involved in the development of HCC and EGF receptor inhibition by TKI is a refined strategy to inhibit tumor growth [254].